EUVIMED · CrossrefZeitschrift
Pharmacogenetics
ISSN 0960-314X · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells
Functionality of allelic variations in human alcohol dehydrogenase gene family
A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma
Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8)
Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants
Differential expression and function of CYP2C isoforms in human intestine and liver
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene
Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations
Effect of two mutations of human CYP1B1, G61E and R469W, on stability and endogenous steroid substrate metabolism
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry
Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms
Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans
Hypothesis: Comparisons of inter- and intra-individual variations can substitute for twin studies in drug research
The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence
CYP1A1 mutations 4887A, 4889G, 5639C and 6235C in the Polish population and their allelic linkage, determined by peptide nucleic acid-mediated PCR clamping
Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution
Increased prevalence of the Taq I A1allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report
Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype??
Human cytochrome from genotype to phenotype
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders
Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy
Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology
Studies on interindividual variations of CYP2E1 using chlorzoxazone as an in vivo probe
Noninvasive tests of CYP3A enzymes
Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxyIation of chlorzoxazone
Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9
EUVIMED